In contrast, a recent study reported a positive association between serum HDL-C and apoA-I levels with BC risk; however, this direct association was only seen in women who had not used hormone replacement therapy (HRT; Martin et al., 2015). The gene discussed is APOA1; the disease is breast cancer.